Kisho is an information platform, not a medical provider. Nothing on this site constitutes medical advice, diagnosis, or treatment recommendations. All content is aggregated from publicly available sources (including ClinicalTrials.gov, PubMed, FDA.gov, and Orphanet) and is provided for informational purposes only. Clinical trial eligibility, treatment decisions, and any health-related actions should always be discussed with a qualified healthcare professional. Kisho does not endorse any specific therapy, organization, or clinical trial. Terms of use · Privacy policy
Features include always present findings: Decreased proportion of memory B cells, Decreased CD4+ T cell proportion, and Decreased CD8+ T cell proportion; and common findings: Cutaneous abscess, Recurrent otitis media, Recurrent respiratory infections, and Recurrent sinusitis. 9 total HPO annotations.
Organ System | Phenotype Count | Example Features |
|---|---|---|
Brain and nerves | 1 | Decreased proportion of memory B cells |
IKBKB encodes inhibitor of nuclear factor kappa B kinase subunit beta (756 aa). Serine kinase that plays an essential role in the NF-kappa-B signaling pathway which is activated by multiple stimuli such as inflammatory cytokines, bacterial or viral products, DNA damages or other cellular stresses. Highest expression in Spleen (67.2 TPM) and Fallopian Tube (52.0 TPM).
Immunodeficiency 15a has been associated with mutations in the IKBKB gene on chromosome 8.
The IKBKB protein participates in IKBKB Q432Pfs*62 and TNFα:TNFR1:TRADD:K63,Met1polyUb, p-S25-RIPK1:BIRC2/3:p-S-CHUK:p-S-IKBKB:IKBKG pathways.
IKBKB is classified as a druggable target (Druggable Genome, Enzyme, Kinase, Serine Threonine Kinase, and Transcription Factor categories) with score 7.5.
Genetic testing for IKBKB is available. Testing is considered supportive for diagnosis.
Phenotype severity distribution: 3 always present features, 4 common features.
No clinical trials have been registered for immunodeficiency 15a.
5 publications have been identified in PubMed for immunodeficiency 15a. Research spans Basic Science / Preclinical (40%), Case Report / Case Series (20%), and Clinical Trial Publication (20%).
Rossmanith R (2026). [PMID: 41518476](https://pubmed.ncbi.nlm.nih.gov/41518476/). *Journal of clinical immunology*. [Case Report / Case Series]
Mushunje PK (2025). [PMID: 41203736](https://pubmed.ncbi.nlm.nih.gov/41203736/). *Scientific reports*. [Clinical Trial Publication]
Mertowska P (2025). [PMID: 40355604](https://pubmed.ncbi.nlm.nih.gov/40355604/). *Scientific reports*. [Basic Science / Preclinical]
Koka PS (2024). [PMID: 38721526](https://pubmed.ncbi.nlm.nih.gov/38721526/). *Frontiers in cell and developmental biology*. [Basic Science / Preclinical]
Morrison S (2024). [PMID: 39085989](https://pubmed.ncbi.nlm.nih.gov/39085989/). *Journal of acquired immune deficiency syndromes (1999)*. [Epidemiology / Natural History]
Data assembled from 6 of 12 sources · Last updated Sep 18, 2026, 6:57 AM UTC
Online Mendelian Inheritance in Man
Genetic and Rare Diseases Info Center
Ears |
1 |
Recurrent otitis media |
Lungs and breathing | 1 | Recurrent respiratory infections |
Blood and immune system | 1 | Recurrent respiratory infections |